News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies – ESMO
Stefan Symeonides/cancer.ed.ac.uk
Dec 11, 2024, 10:27

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies – ESMO

ESMO – Eur. Oncology shared an article by Stefan Symeonides on X:

“Early-phase trials presented at ESMOAsia24 report the potential for two new oral small-molecule ICIs in Solid Tumours showcasing favourable benefit-risk profiles and improved ease of use compared w/ antibodies.”

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies - ESMO

Two oral immune checkpoint inhibitors show preliminary efficacy and manageable safety in early trials.

Authors: Stefan Symeonides, et al.

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies - ESMO

cancer ESMO - Eur. Oncology ESMOASIA24 fight against cancer Global fight against cancer OncoDaily Oncology solid tumours Stefan Symeonides
Special Coverage
Insight
Dec 11, 2024, 10:27
Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies - ESMO
Blog
Dec 11, 2024, 10:23
IASLC - Improving Tobacco Control in Mozambique Through Hospital Registries and the National Cancer Control Program
Blog
Dec 11, 2024, 10:22
Youssef A.: Imagine a tool that could predict a life-threatening condition
Blog
Dec 11, 2024, 10:18
Anne Sophie Kubasch: Presenting the results of the LUCAS and CANFIRE trials at ASH 2024
Career
Dec 11, 2024, 10:04
James Wu: Blessed to have won the CAHON Young Investigator Award
Blog
Dec 11, 2024, 09:59
George Stern: There are actually 7 types of rest we need, explains Saundra Dalton-Smith
Insight
Dec 11, 2024, 09:53
Thomas Powles was appointed Editor-in-Chief of Annals of Oncology
Blog
Dec 11, 2024, 09:53
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center
Blog
Dec 11, 2024, 09:45
Kelly Meza: Incredible experience with amazing friends and mentors at ASH24
Blog
Dec 11, 2024, 09:42
Alejandra Mendez: Fertility preservation ensuring the best possible quality of life after cancer
Blog
Dec 11, 2024, 09:39
Talha Badar: Presenting several abstracts on acute leukemia and myeloid disorders at ASH24
Insight
Dec 11, 2024, 09:32
Nelson Dusetti: Our project COMBAT-PDAC has secured nearly 2 million euros in funding from the EP PerMed